SEC Company Response from vTv Therapeutics (VTVT) — Nov 20, 2025
vTv Therapeutics Inc.
Date: Nov. 20, 2025 · CIK: 0001641489 · Accession: 0001193125-25-289386
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290709
Letter
Re: vTv Therapeutics Inc. Acceleration Request for Registration Statement on Form S-3 File No. 333-290709 Dear Mr. Crawford, Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “ Act ”), vTv Therapeutics Inc. (the “ Company ”) hereby requests that the effective date of the above-referenced registration statement (the “ Registration Statement ”) be accelerated to November 24, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Dechert LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Dechert LLP, by calling David Rosenthal at (212) 698-3616. If you have any questions regarding this request, please contact David Rosenthal of Dechert LLP at (212) 698-3616.
November 20, 2025 Office of Life Sciences Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Daniel Crawford
Sincerely,
VTV THERAPEUTICS INC.
/s/ Michael Tung
Michael Tung
Show Raw Text
CORRESP 1 filename1.htm CORRESP November 20, 2025 Office of Life Sciences Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Daniel Crawford Re: vTv Therapeutics Inc. Acceleration Request for Registration Statement on Form S-3 File No. 333-290709 Dear Mr. Crawford, Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “ Act ”), vTv Therapeutics Inc. (the “ Company ”) hereby requests that the effective date of the above-referenced registration statement (the “ Registration Statement ”) be accelerated to November 24, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Dechert LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Dechert LLP, by calling David Rosenthal at (212) 698-3616. If you have any questions regarding this request, please contact David Rosenthal of Dechert LLP at (212) 698-3616. Sincerely, VTV THERAPEUTICS INC. /s/ Michael Tung Michael Tung Executive Vice President and Chief Financial Officer cc: David S. Rosenthal, Dechert LLP